Inhibition of Glioblastoma Cell Proliferation by Hyaluronan Synthesis Inhibiting Nanoparticles
Delivering therapeutics to a brain tumor is a challenge because of the tightly regulated blood brain barrier (BBB) as well as the dense and sticky extracellular matrix (ECM) composed mainly of hyaluronan and proteoglycans, which play a major role in glioblastoma progression. Several strategies have been employed to treat brain tumors. Here, we utilize nanoparticles to cross the BBB and target the hyaluronan rich matrix to treat the glioblastoma. We have developed poly(lactic-co-glycolic acid) (PLGA) polymeric nanoparticles of around 180 nm in size, surface coated with ApoE-peptides to facilitate the BBB transport, and encapsulated with 4-methylumbelliferone (4-MU), a hyaluronan synthesis inhibitor with anticancer properties, to modulate the brain ECM and subsequently inhibit tumor growth with high therapeutic efficacy. Our results show that the ApoE coated 4-MU nanoparticles significantly inhibit glioblastoma tumor growth compared to 4-MU treatment alone.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: July 1, 2017
More about this publication?
- Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites